News | April 07, 2025
Dr Reddy’s Laboratories gets Rs 2,395 crore show cause notice from IT authority
Dr Reddy’s said scheme of amalgamation was carried with adherence to all the legal requirements including tax laws
Dr Reddy’s said scheme of amalgamation was carried with adherence to all the legal requirements including tax laws
Being a premium partner for pharmaceutical companies by contributing to safety and productivity of pharmaceutical manufacture
Bloom has pioneered a technology to transform plant waste into valuable chemical products
He has global experience in strategic and operational leadership levels with an extensive track record of leadership and success in building companies, businesses, teams, and brands for over 30 years
TB treatment coverage in India increased by 32% in the last eight years from 53% in 2015 to 85% in 2023
VaxiFlu-4 is being marketed by Zydus Vaxxicare-a division of the group focussing on preventives
This strategic partnership will also enable KIMS to exercise call option (not an obligation) to acquire majority stake in UAIMS Hospital in the coming years
Richard A. Gonzalez to retire from the board of directors effective July 1, 2025
Cancer cases in India estimated to reach 1.57 million in 2025
The PATHWAY HER2 (4B5) test, the first and only FDA approved companion diagnostic for assessing HER2-low status since 2022, is now also approved to aid in the assessment of HER2-ultralow status for metastatic breast cancer patients.
Subscribe To Our Newsletter & Stay Updated
